• PDF: Delivered by email usually within 12 to 24 UK business hours.

Taiwan Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Taiwan Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Taiwan Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Taiwan diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Taiwan.

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in Taiwan.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in Taiwan.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
  • 1 Table of Contents
    • 1.1 1.2 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 Diabetes Care Devices
    • 3.2 Glucose Monitoring Devices
      • 3.2.1 Blood Glucose Meters
      • 3.2.2 Blood Glucose Strips
    • 3.3 Insulin Delivery
      • 3.3.1 Insulin Pens
      • 3.3.2 Insulin Syringes
      • 3.3.3 Insulin Pumps
      • 3.3.4 Traditional Insulin Pump Accessories
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
    • 5.2 Pre-market Approval
    • 5.3 Fast-track Approval
    • 5.4 Registration Period
    • 5.5 Labeling and Packaging
    • 5.6 Post-market Surveillance
  • 6 Pricing and Reimbursement
    • 6.1 Reimbursement Application
    • 6.2 Reimbursement Systems
  • 7 Distribution Structure
  • 8 Diabetes Care Devices In Taiwan
    • 8.1 Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Diabetes Care Devices, Taiwan, Overall Revenue ($ mn), 2000-2015
    • 8.3 Diabetes Care Devices, Taiwan, Category Volume (Units), 2000-2015
    • 8.4 Diabetes Care Devices, Taiwan, Company Share (2007-2008)
  • 9 Glucose Monitoring In Taiwan
    • 9.1 Glucose Monitoring Overall Revenue (2000-2015)
      • 9.1.1 Blood Glucose Meters Overall Revenue (2000-2015)
    • 9.2 Glucose Monitoring Overall Volume (2000-2015)
      • 9.2.1 Blood Glucose Meters Overall Volume (2000-2015)
    • 9.3 Glucose Monitoring Average Price (2000-2015)
    • 9.4 Glucose Monitoring Distribution Share (2007-2008)
    • 9.5 Glucose Monitoring, Taiwan, Company Share (2007-2008)
  • 10 Insulin Delivery In Taiwan
    • 10.1 Insulin Delivery Overall Revenue (2000-2015)
      • 10.1.1 Insulin Pens Overall Revenue (2000-2015)
    • 10.2 Insulin Delivery Overall Volume (2000-2015)
      • 10.2.1 Insulin Pens Overall Volume (2000-2015)
    • 10.3 Insulin Delivery Average Price (2000-2015)
    • 10.4 Insulin Delivery Distribution Share (2007-2008)
    • 10.5 Insulin Delivery, Taiwan, Company Share (2007-2008)
  • 11 Overview of Key Companies in Taiwan Diabetes Care Devices Market
    • 11.1 F. Hoffmann-La Roche Ltd
      • 11.1.1 Company Overview
      • 11.1.2 Value Chain Analysis
      • 11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products
    • 11.2 Apex Biotechnology Corp
      • 11.2.1 Company Overview
    • 11.3 LifeScan, Inc
      • 11.3.1 Company Overview
      • 11.3.2 LifeScan, Inc. Pipeline Products
    • 11.4 Becton, Dickinson and Company
      • 11.4.1 Company Overview
      • 11.4.2 Value Chain Analysis
    • 11.5 Terumo Corporation
      • 11.5.1 Company Overview
      • 11.5.2 Value Chain Analysis
    • 11.6 Bayer HealthCare AG
      • 11.6.1 Company Overview
      • 11.6.2 Value Chain Analysis
      • 11.6.3 Bayer HealthCare AG Pipeline Products
    • 11.7 Abbott Laboratories
      • 11.7.1 Company Overview
      • 11.7.2 Value Chain Analysis
      • 11.7.3 Abbott Laboratories Pipeline Products
    • 11.8 Eli Lilly and Company
      • 11.8.1 Company Overview
      • 11.8.2 Value Chain Analysis
      • 11.8.3 Eli Lilly and Company Pipeline Products
    • 11.9 TaiDoc Technology corporation
      • 11.9.1 Company Overview
    • 11.10 Medtronic, Inc
      • 11.10.1 Company Overview
      • 11.10.2 Value Chain Analysis
      • 11.10.3 Medtronic, Inc. Pipeline Products
    • 11.11 ARKRAY, Inc
      • 11.11.1 Company Overview
      • 11.11.2 ARKRAY, Inc. Pipeline Products
    • 11.12 Animas Corporation
      • 11.12.1 Company Overview
    • 11.13 Sanofi-Aventis
      • 11.13.1 Company Overview
    • 11.14 Smiths Medical
      • 11.14.1 Company Overview
      • 11.14.2 Value Chain Analysis
  • 12 Appendix
    • 12.1 Global Markets Direct Research Methodology
    • 12.2 Coverage
    • 12.3 Secondary Research
    • 12.4 Primary Research
    • 12.5 Models
    • 12.6 Forecasts
    • 12.7 Expert Panel Validation
    • 12.8 Currency Conversion
    • 12.9 Contact Us
    • 12.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Public and private Hospitals in Taiwan, 2004
    • Table 2: Healthcare Personnel per 10,000 Population by Locality in Taiwan, 2005
    • Table 3: Specialty Beds in Hospitals by Accreditation in Taiwan, 2005
    • Table 4: Specialty Beds in Hospitals by Accreditation in Taiwan, 2005
    • Table 5: Medical Equipment Pre-market Approval in Taiwan, 2007
    • Table 6: Medical Equipment Evaluation Standards in Taiwan, 2007
    • Table 7: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 8: Diabetes Care Devices, Taiwan, Overall Revenue ($ mn), 2000-2015
    • Table 9: Diabetes Care Devices, Taiwan, Cross-Category Analysis, 2000-2015
    • Table 10: Diabetes Care Devices, Taiwan, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 11: Diabetes Care Devices, Taiwan, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 12: Diabetes Care Devices, Taiwan, Category Volume (Units), 2000-2015
    • Table 13: Diabetes Care Devices, Taiwan, Category Volume (Units), Historic, 2000-2008
    • Table 14: Diabetes Care Devices, Taiwan, Category Volume (Units), Forecast, 2008-2015
    • Table 15: Diabetes Care Devices, Taiwan, Company Share by Revenue ($ mn), 2007-2008
    • Table 16: Glucose Monitoring, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 17: Glucose Monitoring, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 18: Blood Glucose Meters, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 19: Blood Glucose Meters, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 20: Glucose Monitoring, Taiwan, Volume (Units) by Segment, Historic, 2000-2008
    • Table 21: Glucose Monitoring, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 22: Blood Glucose Meters, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 23: Blood Glucose Meters, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 24: Glucose Monitoring, Taiwan, Average Price ($), Historic, 2000-2008
    • Table 25: Glucose Monitoring, Taiwan, Average Price ($), Forecast, 2008-2015
    • Table 26: Glucose Monitoring, Taiwan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 27: Glucose Monitoring, Taiwan, Company Share by Revenue ($ mn), 2007-2008
    • Table 28: Insulin Delivery, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 29: Insulin Delivery, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 30: Insulin Pens, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 31: Insulin Pens, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 32: Insulin Delivery, Taiwan, Volume (Units) by Segment, Historic, 2000-2008
    • Table 33: Insulin Delivery, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 34: Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 35: Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 36: Insulin Delivery, Taiwan, Average Price ($), Historic, 2000-2008
    • Table 37: Insulin Delivery, Taiwan, Average Price ($), Forecast, 2008-2015
    • Table 38: Insulin Delivery, Taiwan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 39: Insulin Delivery, Taiwan, Company Share by Revenue ($ mn), 2007-2008
    • Table 40: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
    • Table 41: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
    • Table 42: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area
    • Table 43: LifeScan, Inc. Pipeline Products by Equipment Type
    • Table 44: LifeScan, Inc. Pipeline Products by Development Stage
    • Table 45: LifeScan, Inc. Pipeline Products by Therapy Area
    • Table 46: LifeScan, Inc. Pipeline Products by Clinical Trials
    • Table 47: LifeScan, Inc. Pipeline Products by News Summary
    • Table 48: Bayer HealthCare AG Pipeline Products by Equipment Type
    • Table 49: Bayer HealthCare AG Pipeline Products by Development Stage
    • Table 50: Bayer HealthCare AG Pipeline Products by Therapy Area
    • Table 51: Bayer HealthCare AG Pipeline Products by News Summary
    • Table 52: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 53: Abbott Laboratories Pipeline Products by Development Stage
    • Table 54: Abbott Laboratories Pipeline Products by Therapy Area
    • Table 55: Abbott Laboratories Pipeline Products by Clinical Trials
    • Table 56: Abbott Laboratories Pipeline Products by News Summary
    • Table 57: Eli Lilly and Company Pipeline Products by Equipment Type
    • Table 58: Eli Lilly and Company Pipeline Products by Development Stage
    • Table 59: Eli Lilly and Company Pipeline Products by Therapy Area
    • Table 60: Eli Lilly and Company Pipeline Products by Clinical Trials
    • Table 61: Eli Lilly and Company Pipeline Products by News Summary
    • Table 62: Medtronic, Inc. Pipeline Products by Equipment Type
    • Table 63: Medtronic, Inc. Pipeline Products By Development Stage
    • Table 64: Medtronic, Inc. Pipeline Products By Therapy Area
    • Table 65: Medtronic, Inc. Pipeline Products By Clinical Trials
    • Table 66: Medtronic, Inc. Pipeline Products By News Summary
    • Table 67: ARKRAY, Inc. Pipeline Products by Equipment Type
    • Table 68: ARKRAY, Inc. Pipeline Products by Development Stage
    • Table 69: ARKRAY, Inc. Pipeline Products by Clinical Trials
    • Table 70: ARKRAY, Inc. Pipeline Products by News Summary
    • Table 71: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Per Capita Healthcare Expenditure in Taiwan, 2000-2004
    • Figure 2: Medical Equipment Pre-Market Approval Process in Taiwan, 2007
    • Figure 3: Medical Equipment Reimbursement Process in Taiwan, 2007
    • Figure 4: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 5: Diabetes Care Devices, Taiwan, Overall Revenue ($ mn), 2000-2015
    • Figure 6: Diabetes Care Devices, Taiwan, Cross-Category Analysis, 2000-2015
    • Figure 7: Diabetes Care Devices, Taiwan, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 8: Diabetes Care Devices, Taiwan, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 9: Diabetes Care Devices, Taiwan, Category Volume (Units), 2000-2015
    • Figure 10: Diabetes Care Devices, Taiwan, Category Volume (Units), Historic, 2000-2008
    • Figure 11: Diabetes Care Devices, Taiwan, Category Volume (Units), Forecast, 2008-2015
    • Figure 12: Diabetes Care Devices, Taiwan, Company Share (%), 2008
    • Figure 13: Glucose Monitoring, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 14: Glucose Monitoring, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 15: Blood Glucose Meters, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 16: Blood Glucose Meters, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 17: Glucose Monitoring, Taiwan, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 18: Glucose Monitoring, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 19: Blood Glucose Meters, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 20: Blood Glucose Meters, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 21: Glucose Monitoring, Taiwan, Company Share (%), 2008
    • Figure 22: Insulin Delivery, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 23: Insulin Delivery, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 24: Insulin Pens, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 25: Insulin Pens, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 26: Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 27: Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 28: Insulin Delivery, Taiwan, Company Share (%), 2008
    • Figure 29: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 30: Becton, Dickinson and Company Value Chain Analysis
    • Figure 31: Terumo Corporation Value Chain Analysis
    • Figure 32: Bayer HealthCare AG Value Chain Analysis
    • Figure 33: Abbott Laboratories Value Chain Analysis
    • Figure 34: Eli Lilly and Company Value Chain Analysis
    • Figure 35: Medtronic, Inc. Value Chain Analysis
    • Figure 36: Smiths Medical Value Chain Analysis
    • Figure 37: Global Markets Direct Methodology
+44 20 8816 8548

Ask a question about Taiwan Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Enter the characters you see in the picture below
Captcha